FDA Publishes Proposed Rule on Sections 503A and 503B Compounding | McDermott Will & Emery
On March 20, 2024, the US Food & Drug Administration (FDA) issued a proposed rule titled Drug Products or Categories of Drug Products that Present Demonstrable Difficulties for...
Source: jdsupra.com